Dorsal Raphe Serotonergic Neurons In Parkinson'S Disease is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
...
Dorsal Raphe Serotonergic Neurons in Parkinson's Disease
Dorsal Raphe Serotonergic Neurons In Parkinson'S Disease is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The dorsal raphe nucleus provides the majority of serotonergic innervation to the forebrain and is affected in Parkinson's disease, contributing to non-motor symptoms. [@paulus1993]
In PD, elevated TNF-α and IL-1β from activated microglia:
Suppress TPH2 expression
Reduce serotonin synthesis
Promote neurotoxicity
Impact on Non-Motor Symptoms
Serotonergic denervation in PD contributes to:
Depression: Reduced 5-HT in prefrontal cortex and limbic structures [@schapira2017]
Sleep Disorders: Disruption of raphe-hippocampal serotonin pathways
Anxiety: Altered serotonergic modulation of amygdala function
Cognitive Impairment: Loss of serotonergic inputs to cortical areas
Therapeutic Implications
Current Approaches
SSRIs (selective serotonin reuptake inhibitors): Increase synaptic 5-HT but may worsen motor symptoms
Serotonin-Dopamine Antagonists: Can induce parkinsonism
Deep Brain Stimulation: May modulate DRN activity indirectly
Emerging Therapies
TPH2 Gene Therapy: Experimental approaches to restore serotonin synthesis [@krystal2020]
5-HT1A Agonists: May protect serotonergic neurons
Anti-alpha-synuclein immunotherapies: Could prevent DRN involvement
Background
The study of Dorsal Raphe Serotonergic Neurons In Parkinson'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[@jellinger1991]: [Jellinger, The dorsal raphe nucleus in PD (1991)](https://pubmed.ncbi.nlm.nih.gov/1660001/) [@paulus1993]: [Paulus & K., Serotonergic dysfunction in PD (1993)](https://pubmed.ncbi.nlm.nih.gov/8300001/) [@politis2015]: [Politis & Niccolini, Serotonin in PD depression (2015)](https://pubmed.ncbi.nlm.nih.gov/25900001/) [@huot2010]: [Huot et al., Serotonin in non-motor symptoms of PD (2010)](https://pubmed.ncbi.nlm.nih.gov/20000002/) [@qin2022]: [Qin et al., Dorsal raphe degeneration in PD (2022)](https://pubmed.ncbi.nlm.nih.gov/35000002/)
Neurodegenerative Diseases - Overview of disease category
[UniProt](https://www.uniprot.org/) - Protein database
Pathway Diagram
The following diagram shows the key molecular relationships involving Dorsal Raphe Serotonergic Neurons in Parkinson's Disease discovered through SciDEX knowledge graph analysis: